Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1989-09-29
1992-08-18
Nucker, Christine
Chemistry: molecular biology and microbiology
Spore forming or isolating process
436543, 436811, 435 72, 435 724, 435974, 435 693, 435 701, 435 5, C12N 510
Patent
active
051399474
ABSTRACT:
The invention is a cloned T cell prepared by infecting a human T cell, H9, with HTLV-III B, which cloned human T cell is antigenic for HTLV-III B, does not have a syncytium-forming activity, and does not produce infectious HTLV-III B virions.
REFERENCES:
Popovic, et al., Detection, Isolation & Continuous . . . Pre-AIDS Science 224, 497-500, May 1984.
Harada et al., Infection of HTLV-III/LAV in HTLV-I . . . Assay Science 229, 563-566, Aug. 1985.
Tsai et al., Inhibition of HIV Infectivity by Chloroquine, Int. Conf. on AIDS, Jun. 4-9, 1989 Abstract Only.
Hamamoto Yoshiaki
Kobayashi Nobuyuki
Yamamoto Naoki
Banyu Pharmaceutical Co. Ltd.
Nucker Christine
Stucker Jeffrey
LandOfFree
Antigenic noninfectious HIV-producing cloned T cell does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigenic noninfectious HIV-producing cloned T cell, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic noninfectious HIV-producing cloned T cell will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1248666